Professional peptide High Purity CAS 16960-16-0 Cosyntropin (Tetracosactide) with Safe Delivery
- Κατασκευαστής: Dewael
- Δοκιμασία προϊόν: 99%+
- Εμφάνιση:White lyophilized powder
- Τόπο καταγωγής: Κίνα
- Πιστοποίηση: SGS,ISO9001, GMP
- Ελάχιστη ποσότητα παραγγελίας: 100ml
- λεπτομέρειες συσκευασίας: Διακριτική τρόπους συσκευασίας για τα τελωνεία Pass Εγγυημένα
- Ωρα παράδοσης: Στα πλαίσια 12 ώρες μετά τη λήψη της πληρωμής σας
- Οροι πληρωμής: Δυτική Ένωση, MoneyGram,Bitcoin,Τραπεζική μεταφορά
- Αποστολή: EMS,DHL,Fedex,UPS,TNT και ούτω καθεξής.
- Πολιτική: Re-Shipping Πολιτική
- δυνατότητα εφοδιασμού: 500-600Λίτρα / μήνα
Professional peptide High Purity CAS 16960-16-0 Cosyntropin with Safe Delivery
Βασικές πληροφορίες:
όνομα προϊόντος:Tetracosactide,Cosyntropin,Tetracosactrin,acortan
Καθαρότητα: 99%
Αριθμός μητρώου CAS: 16960-16-0
Einecs Αρ: 241-031-1
MF: C136H210N40O31S
MW: 2933.47
Σημείο τήξης: 2 ° C
Boiling point: 225° C
Refractive index: 1.551-1.553
Εμφάνιση: Colorless transparent liquid
Βαθμός: Pharmceutical Grade
Αποθήκευση: Σκίαση, περιορισμένη διατήρηση
Χρήση: Cosyntropin (cortrosyn) is a synthetic derivative of adrenocorticotropic hormone (ACTH) that is used in the ACTH stimulation test to evaluate and diagnose cortisol disorders.
Περιγραφή:
Tetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
Εφαρμογή:
In patients with low cortisol levels or symptoms of adrenocortical insufficiency, cosyntropin can be used to diagnose Addison’s disease. A failure for serum cortisol levels to increase after administration of cosyntropin makes a diagnosis of primary adrenocortical insufficiency more likely. An increase in cortisol upon administration of cosyntropin rules out the condition. The test may also be used to assess the function of the adrenal glands after successful treatment for Cushing’s syndrome.
Cosyntropin is also used in the opposite situation, when there is aldosterone hypersecretion due to either a unilateral adrenal adenoma (which is treated by surgical removal) or bilateral adrenal hyperplasia (treated by oral). A procedure called adrenal venous sampling may be used pre-operatively to localize the source of aldosterone hypersecretion from either adrenal gland. A peripheral intravenous infusion of Cosyntropin before and during the procedure stimulates cortisol production and thereby verifies catheter position.
———————————————————————————————————————————————————————————————————————————————————————-
Επικοινώνησε τώρα
Κριτικές
Δεν υπάρχουν σχόλια ακόμη.